CareRx Reports 2025 Year-End and Fourth Quarter Results

Core Insights - CareRx Corporation reported strong financial results for the fourth quarter and full year ended December 31, 2025, highlighting significant year-over-year growth in Adjusted EBITDA and improved EBITDA margins [2][3][9] Financial Performance - Revenue for the year reached CAD 370.2 million, a slight increase from CAD 366.7 million in 2024, while fourth-quarter revenue was CAD 96.1 million, up from CAD 92.2 million in Q4 2024 [3][9] - Adjusted EBITDA for the year was CAD 32.9 million, compared to CAD 30.3 million in 2024, and for Q4 2025, it was CAD 8.8 million, up from CAD 7.6 million in Q4 2024 [3][9] - Adjusted EBITDA margin improved to 8.9% for the year and 9.2% for Q4 2025, compared to 8.3% and 8.2% in the respective prior periods [3][9] - Net income for the year was CAD 26.1 million, a significant recovery from a loss of CAD 4.5 million in 2024, with Q4 net income at CAD 23.8 million compared to a loss of CAD 2.2 million in Q4 2024 [3][9] - Cash provided by operations was CAD 9.6 million for Q4 2025, compared to CAD 8.4 million in Q4 2024 [3][9] Operational Highlights - Average beds serviced increased to 92,250 in Q4 2025, up from 87,658 in Q4 2024, reflecting the company's expansion efforts [9] - The company expanded its platform by adding over 4,500 additional beds during the year [2][9] - Net Debt decreased to CAD 27.1 million, down from CAD 35.8 million in 2024, indicating improved financial leverage [10][16] Dividend Announcement - The Board of Directors declared a dividend of CAD 0.02 per common share, payable on April 9, 2026, to shareholders of record as of March 19, 2026 [4]